Recombinant human phenylalanine hydroxylase (hPAH) expressed in Escherichia coli for 24 h at 28°C has been found by two-dimensional electrophoresis to exist as a mixture of four to five molecular forms as a result of nonenzymatic deamidation of labile Asn residues. The multiple deamidations alter the functional properties of the enzyme including its affinity for Lphenylalanine and tetrahydrobiopterin, catalytic efficiency, and substrate inhibition and also result in enzyme forms more susceptible to limited tryptic proteolysis. Phenylalanine hydroxylase (PAH, 1 phenylalanine 4-monooxygenase, EC 1.14.16.1) is a non-heme iron monooxygenase that catalyzes the hydroxylation of L-phenylalanine (L-Phe) to L-tyrosine (L-Tyr) in the presence of the natural cofactor (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin (H 4 biopterin) and dioxygen. Mutations in the human enzyme (hPAH) leading to altered kinetic properties or reduced stability of the enzyme are associated with the autosomal recessive disorder phenylketonuria (PKU). hPAH isolated from liver (2) and as recombinant enzyme expressed in Escherichia coli (3, 4) has been found to exist as a mixture of 4 -5 molecular forms with the same apparent subunit molecular mass, but with different isoelectric points (pI). Isoelectric focusing and two-dimensional electrophoresis of recombinant hPAH expressed in E. coli for 24 h at 28°C revealed five components of decreasing staining intensity and decreasing pI (denoted hPAH I-V). This microheterogeneity was shown to be the result of nonenzymatic deamidations of Asn residues (1, 4). Mainly one band with the highest pI (hPAH I) was, however, detected after a short induction period of 2 h at 28°C, and this form was considered to represent the newly synthesized and most native, nondeamidated form of the enzyme. Thus, the microheterogeneity pattern is highly dependent on the induction time with IPTG in E. coli (4). Due to the relatively high rate of deamidation, the labile amide-containing residues have been considered to be Asn residues (4), and this conclusion has recently been confirmed by the demonstration of iso-Asp in several tryptic peptides of the highly deamidated full-length wt-hPAH (1). In the deamidation reaction Asn is converted to Asp and iso-Asp in a variable ratio, sometimes with iso-Asp as the main product (5, 6). The rate of Asn deamidation in proteins and peptides has been shown to be dependent on pH, temperature, and ionic strength (7) and on intrinsic factors like the nearest neighbor amino acids, particularly the residue in the (n ϩ 1) position (8 -10). The deamidation proceeds via a cyclic succinimide intermediate (6), and with glycine in the n ϩ 1 position the rate of deamidation is unusually rapid, whereas all the other 19 amino acid residues are more sterically hindered in the formation of the cyclic intermediate (11) . Moreover, the rate of deamidation is also determined by the protein secondary and tertiary structure because the necessary flexibility for the formation of the cyclic intermediate may be limited in proteins (12). The fact that deamidation is an
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The sequence of hPAH contains 16 Asn residues, but only about 4 -5 are expected to be involved in the deamidations that occur in the enzyme on 24-h expression in E. coli (4) . On the basis of a computer algorithm that estimates the deamidation rates by taking into account the nearest neighbor amino acids and the three-dimensional structure of the protein (16) , the relative deamidation rates of all the Asn residues in hPAH have been predicted (17) . We have recently verified that Asn 32 (followed by a glycine residue), Asn 28 , and Asn 30 in a loop region of the N-terminal autoregulatory sequence (residues 19 -33) of wt-hPAH are among the susceptible residues (1). On the basis of the computational method two other labile residues have been predicted to be located in the catalytic domain structure, i.e. Asn 133 and Asn 376 (17) . Here we present experimental data verifying this prediction based on MALDI-TOF mass spectrometry of tryptic peptides and site-directed mutagenesis. Mutagenesis was also used to characterize the structural and functional effects of single Asn 3 Asp substitutions at 8 alternative positions in the catalytic domain. Moreover, the functional effects of deamidation of Asn 32 are further studied in mutant forms with special reference to its effect on the rate of phosphorylation of Ser 16 by PKA, used as a conformational probe.
EXPERIMENTAL PROCEDURES
Site-directed Mutagenesis-The mutations in the catalytic domain were introduced into the wt-hPAH cDNA by PCR-based site-directed mutagenesis (18) using the pMAL-hPAH vector, containing the factor Xa cleavage site (New England Biolabs) as a template (19) , and the specific oligonucleotide primers listed in Table I . The target sequences for mutagenesis were the restriction endonuclease fragments XbaI/ BamHI (N133D, N167D, and N167I), XhoI/BamHI (N207D), XhoI/AflII (N223D), and BamHI/AflII (N376D, N393D, N401D, and N426D). The three mutations in the regulatory domain and the double mutant N32D/ N376D were introduced into the pMAL-hPAH expression system containing the enterokinase cleavage site (D 4 K) (New England Biolabs) using the QuikChange TM site-directed mutagenesis kit (Stratagene) and the specific oligonucleotides listed in Table I . Authenticity of mutagenesis was verified by DNA sequencing using the malE and 13B oligonucleotides (20) and the Big Dye TM Terminator Ready Reaction Mix (PerkinElmer Life Sciences) in an ABI Prism TM 377 DNA Sequencer (PerkinElmer Life Sciences). MWG-Biotech AG provided primers for mutagenesis and sequencing. Some of the mutants were also verified by MALDI-TOF mass spectrometry of the isolated recombinant enzyme (see "Results").
Expression and Purification of the Enzymes-The wild-type and the mutant forms of hPAH were expressed as fusion proteins in E. coli (TB1 cells) using the maltose-binding protein as a fusion partner (21) . Cells were grown at 37°C, and expression was induced at 28°C by the addition of 1 mM isopropyl thio-␤-D-galactoside (IPTG). The cells expressing wt-hPAH were harvested after 2 and 24 h of induction, and the mutant forms were isolated after an induction period of 2 h, except where otherwise stated. After protein purification by affinity chromatography (amylose resin, 4°C), the fusion proteins were cleaved for 5 h at 4°C by the restriction protease enterokinase (Invitrogen) using 4 units of protease/mg of fusion protein or by factor Xa (from Protein Technology ApS, Denmark) using a protease to substrate ratio of 1:200 (by mass). The tetrameric forms were isolated by size-exclusion chromatography at 4°C using a HiLoad Superdex 200 HR column (1.6 ϫ 60 cm), prepacked from Amersham Biosciences.
Mass Spectrometry-Matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) spectra of tryptic peptides were acquired on a 4700 Proteomic Analyzer (Applied Biosystems Inc.) in the reflectron positive-ion mode and were externally mass calibrated. The instrument was supplied with a software tool that uses a scanning algorithm to (21) , but the catalase concentration was 0.1 g/l, and the enzyme was activated by prior incubation (5 min) with L-Phe. Moreover, 0.5% (w/v) bovine serum albumin was included in the reaction mixture to stabilize the diluted purified enzyme. The enzyme source was either isolated cleaved tetrameric form or purified tetrameric fusion protein in the case of the N167I mutant, and the reaction time was 1 min. The steady-state kinetic data were analyzed by nonlinear regression analysis using the SigmaPlot® Technical Graphing Software and the modified Hill equation of LiCata and Allewell (22) for cooperative substrate binding as well as substrate inhibition (4, 23) . In some experiments 1 mM L-Phe was added either at the start of the preincubation period or together with 75 M pterin cofactor (H 4 biopterin) at the initiation of the hydroxylation reaction. A 3-min time course was then followed in order to study the effect of preincubation with L-Phe on the specific activity of the wild-type and mutant forms of hPAH.
Proteolysis by Trypsin-Limited proteolysis of the wild-type and mutant tetrameric forms was performed at 25°C and a protease to hPAH ratio of 1:200 (by mass). At timed intervals (0 -60 min) aliquots were removed and subjected to SDS-PAGE (24) , and the band corresponding to the full-length subunit was quantified. For peptide analysis by mass spectrometry and reversed-phase chromatography, tryptic proteolysis of hPAH was performed in 20 mM Na-HEPES buffer, pH 7.0, at 30°C for 2 h at a trypsin to substrate ratio of 1:10 (by mass). Soybean trypsin inhibitor was added at the end with a protease to inhibitor ratio of 1:1.5 (by mass).
Reversed-phase Chromatography-The mutant tetrameric enzymes were 32 P-labeled by phosphorylation with PKA (see below), proteolyzed by trypsin, and incubated at 37°C up to 32 h to determine the rate of deamidation of labile Asn residues in the phosphopeptide(s) (1) . At different time points the incubated peptide mixture was subjected to reversed-phase chromatography using a ConstaMetric gradient System (Laboratory Data Control) and a 4.6-mm ϫ 10-cm Hypersil ODS C18 column (Hewlett-Packard) fitted with a 2-cm guard column of the same material. Solvent A was 50 mM ammonium acetate (pH 8.0) and solvent B 50 mM ammonium acetate in 70% (v/v) acetonitrile (pH 8.0). A linear gradient of 10 -50% solvent B was used at a flow rate of 1 ml/min for 60 min (1) . Samples were collected every 15 s, and the elution pattern of phosphopeptides was analyzed by liquid scintillation counting and resolved into individual components, using the Peak Fit software program (SPSS Inc., Chicago); the "auto-fit II-Residuals" was used with the confidence level set at Ն95%.
Phosphorylation by PKA-The time course for the phosphorylation by PKA of Ser 16 in tetrameric wt-hPAH and its mutant forms (5 M subunit) was performed at 30°C in a medium containing 15 mM Na-HEPES, 3 mM dithiothreitol, 0.03 mM EDTA, 0.1 mM EGTA, 10 mM magnesium acetate, 60 M ATP ([␥-32 P]ATP from Amersham Biosciences), and 50 nM of PKA catalytic subunit. The initial rate of phosphorylation and its mean Ϯ S.E. was estimated by nonlinear regression analysis of the 15 individual data points collected within the first 2.5 min (three data points at each time point) (25) . The Student's t test was used for the statistical analysis.
RESULTS

Expression and Purification of wt-hPAH and Its Mutant
Forms-The introduction of extra negative charges in wthPAH as a result of nonenzymatic deamidation during a 24-h expression period at 28°C in the E. coli pMal system has been shown to increase the solubility and recovery of recombinant wt-hPAH relative to the 2-h expressed enzyme (4). The expression of the Asn 3 Asp mutant forms of hPAH resulted in a variable but generally increased yield of fusion proteins (relative to wt-hPAH) after an IPTG induction period of only 2 h at 28°C. Size-exclusion chromatography of the affinity-purified mutant fusion proteins (data not shown) revealed a pattern of oligomerization (tetramers Ͼ Ͼ dimers) similar to that of wthPAH (21, 26, 27) . Moreover, after their cleavage by restriction protease, no significant amount of aggregated enzyme forms was observed in the size-exclusion chromatographic profiles. One-dimensional SDS-PAGE analysis of all the mutant forms revealed the same relative electrophoretic mobility as for the wt-hPAH protomer, both as uncleaved and cleaved fusion protein (data not shown).
Mass Spectrometry-To identify the labile Asn residues in wt-hPAH and ⌬N-(1-102)/⌬C-(429 -452)-hPAH forms, their tryptic peptides were analyzed by MALDI-TOF mass spectrometry. For wt-hPAH expressed for 2 h at 28°C, the matching peptides covered 11 of the total 16 Asn residues in the protein, and on isotopic deconvolution of the mass spectra (28) all the peptides revealed a single monoisotopic mass peak ([M ϩ H ϩ ]) (Table II (Table II) ; the apparent intensity ratio of the two mass peaks 2912.36/2913.36 was ϳ2.5:1 (Fig. 1A) . For comparison, the tryptic peptide of the Asn 376 3 Asp mutant form revealed only a single monoisotopic peak of m/z 2913.36 (Fig. 1B) . The tryptic peptide of ⌬N-(1-102)/⌬C-(429 -452)-hPAH truncated form expressed for 24 h at 28°C gave a similar result as the wt-hPAH 24 h (data not shown). However, in this case also the 20-residue peptide (Phe 131 -Lys 150 ) containing Asn 133 , with a single monoisotopic peak at m/z 2193.06 in the 2-h expressed enzyme (Table II) , revealed on 24-h expression an additional peak at m/z 2194.07; the apparent intensity ratio of the two mass peaks 2193.06 was ϳ14.1:1 (Fig. 1C ). For comparison, the tryptic peptide of the Asn 133 3 Asp mutant form revealed only one monoisotopic peak at m/z 2194.07 (Fig.  1D) .
Steady-state Kinetic Properties of Tetrameric Wild-type and Asn 3 Asp Mutant Forms of hPAH-For tetrameric wt-hPAH
it has been shown (4) that partial but multiple deamidated forms of hPAH change the catalytic properties of the enzyme. In the present study ( Fig. 2 and Table III ) the catalytic effi- ciency (k cat /[S] 0.5 ) of the multiple deamidated wt-hPAH (24-h induction at 28°C) was found to be about 3-fold higher than for the nondeamidated enzyme (2-h induction), i.e. 1.83 versus 0.72 M Ϫ1 ⅐min Ϫ1 , due to an increase (by 55%) in the V max and a reduction (by 46%) in the [S] 0.5 (L-Phe) value. Some of the Asn 3 Asp mutant tetramers (2-h induction) resulted in changes in the steady-state kinetic parameters comparable with those observed as a result of the deamidations of wt-hPAH (24-h induction), notably the N32D mutation in the regulatory domain and the mutations N167D and N376D in the catalytic domain (Table III) . The largest increase (k cat /[S] 0.5 ϭ 1.58) was observed for the N376D mutant tetramer which revealed an increase (by 69%) in V max and a reduction (by 33%) in the [S] 0.5 (L-Phe) value compared with the wild-type control (2-h induction) (Table III) . By contrast, a considerable reduction in catalytic efficiency was observed for the N207D, N223D, and N426D mutant tetramers, whereas no significant change was detected for the N393D mutant form (Table III) , which revealed both reduced V max and [S] 0.5 value for L-Phe.
An increased positive kinetic cooperativity of L-Phe binding as well as a substrate inhibition are also characteristic properties of multiple deamidated (24-h induction at 28°C) wthPAH (4). The N32D, N167D, N376D, N401D, and N32D/ N376D mutant tetramers revealed all the same positive cooperativity (1.8 Ͻ h Ͻ 2.0) as the multiple deamidated wthPAH as well as a substrate inhibition at L-Phe concentrations Ͼ1 mM (Table III) . By contrast, the other Asn 3 Asp mutant forms did not reveal any substrate inhibition within the selected concentration range of L-Phe (Յ4 mM). For the N133D and N426D mutant forms a positive cooperativity (1.4 Ͻ h Ͻ 1.6) comparable with wt-hPAH (2-h induction) (h ϭ 1.5) was observed, whereas no significant cooperativity (0.8 Ͻ h Ͻ 1.2) was found for the N207D, N223D, and N393D mutant tetramers.
A slightly reduced affinity for the natural pterin cofactor has been observed for multiple deamidated hPAH when compared with the nondeamidated enzyme (4), and in the present study a 29% increase in the K m (H 4 biopterin) value was observed for the wt-hPAH (24-h induction). The N167D, N223D, N376D, and N401D mutant forms also demonstrated a significant increase in the K m value for the natural pterin cofactor, i.e. by 19 -39%, compared with wt-hPAH (2-h induction) (Table III) . By contrast, the N133D and N426D mutants revealed an affinity for the pterin cofactor comparable with wt-hPAH (2-h induction), whereas a reduction in the K m value by 74 and 35% was observed for the N207D and N393D mutants, respectively (Table III) .
Effect of Preincubation with L-Phe on the Catalytic Activity-A characteristic property of tetrameric wt-hPAH is also that preincubation with L-Phe resulted in an activation of the enzyme catalytic activity, and that the measured fold activation varied with the time of preincubation (4) due to a relatively slow substrate-induced hysteretic conformational transition (29) . To study the effect of the Asn 3 Asp mutations on the activation process, the catalytic activities of both nondeamidated wt-hPAH and the mutant tetramers (2-h induction) were measured in the presence and absence of preincubation with 1 mM L-Phe. Table III shows that a 5-7-fold activation was observed for the N133D, N376D, N401D, and N426D mutant tetramers, which is in the same range of activation as observed for the 24-h-induced multiple deamidated wt-hPAH (5.8-fold) ( Table III) . The N167D, N223D, and N393D mutant tetramers revealed a lower degree of activation (i.e. 2.7-3.8-fold) than the wt-hPAH (2-h induction) (4.9-fold), whereas no L-Phe activa- tion was observed for the N207D mutant form (Table III) . Interestingly, the Asn 32 3 Asp mutant tetramer revealed the same degree of activation as the wt-hPAH (2-h induction), whereas an increased basal catalytic activity with almost no further stimulation by preincubation with Phe was observed for the Gly 33 3 Ala/Val mutations (Table III) . Limited Proteolysis by Trypsin-Limited proteolysis by trypsin has been shown to represent a sensitive conformational probe in wt-hPAH (4) and some of its disease-associated mutant forms (26) . That nondeamidated hPAH (2-h induction) was more resistant to limited proteolysis by trypsin than multiple deamidated hPAH (24-h induction) (4) was confirmed in the present time course studies, with about 85 and 52% of the full-length protomer recovered for the nondeamidated and multiple deamidated forms of wt-hPAH, respectively, after incubation for 15 min at a trypsin:protein ratio of 1:200 (by mass) (data not shown). Moreover, 6 of 8 Asn 3 Asp mutant tetramers (i.e. N167D, N207D, N223D, N376D, N393D, and N401D) revealed a variable but increased susceptibility to limited proteolysis when compared with the nondeamidated wild-type enzyme (2-h induction). The N207D mutant form was most susceptible to degradation, because only 19% full-length protomer Table III. was recovered after 15 min. By contrast, the N133D and N426D mutants gave a similar rate of proteolysis as the wthPAH (2-h induction) (data not shown).
Phosphorylation of hPAH-In wt-hPAH Ser 16 was a substrate for the catalytic subunit of PKA, and its phosphorylation sensitized the enzyme toward activation by L-Phe (30) . Moreover, the rate of this phosphorylation was conformation-sensitive and was stimulated by L-Phe binding, whereas BH 4 acted as a negative effector (30) . In this study, we have further observed that the initial rate of phosphate incorporation was about 20% higher (p Ͻ 0.003) for the multiple deamidated enzyme (24-h induction) than for the nondeamidated enzyme (2-h induction) hPAH (Fig. 3) . The N32D mutant form (2-h induction) also resulted in an enhanced rate of phosphorylation by PKA (Fig. 3) , comparable (p Ͻ 0.2) to the deamidated wthPAH (24-h induction), whereas the G33A/G33V mutant forms (2-h induction) and the G33A (24-h induction) were phosphorylated with a similar initial rate as the nondeamidated wt (2-h expression) enzyme (Fig. 3) .
Reversed-phase Chromatography of Tryptic Peptides-Together with Asn 28 and Asn 30 , the very labile Asn 32 is part of a cluster of Asn residues in the 28-residue N-terminal tryptic peptide (Leu 15 -Lys 42 ), which also includes Ser 16 . Upon its phosphorylation with PKA and tryptic proteolysis, the 32 Plabeled peptides were resolved by reversed-phase chromatography into some minor phosphopeptides and a major component (t R ϳ34 min), which revealed a time-dependent shift to a more hydrophilic position (t R ϳ31 min) when incubated at 37°C (1) . When the phosphopeptides resulting from tryptic proteolysis of the N32D and G33A/G33V mutant enzymes were subjected to reversed-phase chromatography, the major peptide of N32D revealed the expected retention time of t R ϳ31 min, while that of G33A/G33V mutant derived peptide eluted with a t R ϳ36 min, and none of them shifted on further incubation at pH 7 and 37°C (Fig. 4) (results not shown for G33V) . The minor components in the chromatograms can be explained as the result of alternative tryptic cleavage sites (1).
DISCUSSION
The microheterogeneity of recombinant wt-hPAH expressed in E. coli observed on isoelectric focusing and two-dimensional electrophoresis has been shown to be the result of multiple nonenzymatic deamidations of Asn residues (1, 4). In general, such protein deamidations have been related to their aging and turnover in vivo (10, 31) , which is also the case for hPAH. First, on expression of recombinant hPAH in E. coli, this post-translational modification was found to increase progressively with increasing induction time with IPTG and not to be related to the purification or storage of the enzyme. Second, highly deamidated forms of the enzyme are more susceptible to limited proteolysis by trypsin as compared with the nondeamidated form (4). Finally, PAH purified from human and monkey liver has also been reported to consist of multiple molecular forms on two-dimensional electrophoresis (2), which suggests that nonenzymatic deamidation of Asn residues plays a role in the regulation of the catalytic activity and the cellular turnover of PAH in the hepatocytes in vivo.
Asn Residues Undergoing Deamidation in Recombinant hPAH-Based on a recently developed computer algorithm (10, 16) , several candidate Asn residues have been predicted in the regulatory and catalytic domains of hPAH (17) . The deamidation of the predicted residues in the autoregulatory sequence of the N-terminal regulatory domain (Asn 28 , Asn 30 , and Asn 32 ) has been confirmed recently (1) by MALDI-TOF mass spectrometry, with Asn 32 as the most labile residue. This deamidation has been studied further in the present study by reversedphase chromatography of the phosphorylated ( 32 P-labeled) N-terminal tryptic peptide (Leu 15 -Lys 42 ) of the mutant N32D and G33A/G33V enzymes. The phosphopeptide of the N32D mutant form was eluted with the same retention time as the deamidated peptide of wt-hPAH incubated at 37°C (main peak at t R ϳ31 min) (Fig. 4) (1) . By contrast, the phosphopeptides of the G33A/G33V mutant enzymes were eluted with a higher retention time (t R ϳ36 min) (Fig. 4) comparable with that observed for the peptide of nondeamidated wt-hPAH (main peak at t R ϳ34 min) (1); the small difference in retention time may be explained by the substitution of a Gly with a larger aliphatic residue. Thus, as expected from studies on model peptides (10), the Gly 33 3 Ala/Val mutations stabilize Asn
32
(see also Fig. 3 ).
On the basis of the amino acid sequence and higher order structure, the mentioned computer algorithm (16, 32) estimated a very low deamidation coefficient (C D ϭ 5.5) for Asn 376 , indicating that it is one of the most labile Asn residues in the catalytic domain (Table IV) . This prediction was verified by MALDI-TOF mass spectrometry and site-directed mutagenesis. Thus, the tryptic peptide Thr 373 -Lys 392 of the wt-hPAH (24-h induction) was resolved into two monoisotopic ([M ϩ H ϩ ]) peaks corresponding to nondeamidated (Asn) forms (Table II) and deamidated (Asp/iso-Asp) forms (Fig. 1A) , whereas the N376D mutant revealed only one monoisotopic peak corresponding to an Asp residue in this 25-residue peptide (Fig. 1B) . By contrast, two alternative deamidation coefficients were estimated for Asn 133 on the basis of the three-dimensional structure of the ⌬N-(1-117)-hPAH (C D ϭ 4.1) and the ⌬N-(1-102)/ ⌬C-(429 -452)-hPAH (C D ϭ 73) truncated forms (Table IV) . The different C D values probably reflect an effect of the regulatory and tetramerization domains on the stability of Asn 133 . In the full-length wt-hPAH the native three-dimensional structure may contribute to additional structural constraints that protect against deamidation of Asn 133 . Thus, only one monoisotopic peak, corresponding to an asparagine residue at position 133, was found in the Phe 131 -Lys 150 tryptic peptide for the wt-hPAH (24 h), and only a minor deamidated form was recovered in the same peptide from the ⌬N-(1-102)/⌬C-(429 -452)-hPAH truncated from (Fig. 1C) . These results, together with the deamidation coefficient estimated for this residue in the phosphorylated form of rPAH-⌬C22 (17) , show that Asn 133 represents the second labile Asn in the catalytic domain of hPAH.
Site-directed Mutagenesis-Mutagenesis (Asn 3 Asp) of the three labile Asn residues Asn 32 , Asn 376 , and Asn 133 has provided useful models to study the contribution of each single Asn deamidation to the changed functional properties that occur in wt-hPAH on long term expression in E. coli. It should be noted, however, that the introduction of a negative charge by Asn 3 Asp mutagenesis does not fully account for the effect of deamidation of wt-hPAH in which iso-Asp might also be formed. The generation of an iso-Asp residue, which is a regular product of the deamidation reaction, also results in a conformational change because it adds an extra carbon to the polypeptide backbone (33) . Thus, the formation of iso-Asp has been shown recently for the deamidation of alternative Asn residues in wt-hPAH including Asn 32 (1), as expected from the Asn 32 -Gly 33 sequence and the high crystallographic B factor observed for this region in the crystal structure of rPAH (34) .
The N32D mutation revealed catalytic properties similar to that of multiple deamidated wt-hPAH (24 h expression), i.e. an increased catalytic efficiency and an increased positive cooperativity of L-Phe binding and substrate inhibition (Table III) , whereas substitution of Gly 33 with Ala/Val residues, which prevents the deamidation of Asn 32 , resulted in enzyme preparations with kinetic properties similar to that observed for wt-hPAH (2-h expression). Moreover, the N32D mutant form and the wt-hPAH (24 h) showed similar increased rates of phosphorylation of Ser 16 by PKA when compared with the G33A and G33V mutant forms and the wt-hPAH (2 h) (Fig. 3) . Deamidation of Asn 32 into an Asp/iso-Asp residue adds a negative charge to the side chain that results in an electrostatic repulsion notably from Asp 84 (1) and results in a conformational change, as determined by its effect on the rate of phosphorylation of Ser 16 by PKA. Deamidation of Asn 32 seems to be the only determinant for this effect, because the partial deamidation of the other asparagine residues, which occur in the G33A mutant form on 24-h induction, did not affect the initial rate of phosphorylation (Fig. 3) .
In the catalytic domain, Asn 376 was shown to represent the most labile Asn residue. In the crystal structure it is located at the beginning of a loop (designated the 380-loop) that represents one limiting side of the active site crevice structure (35) (Table IV; Fig. 5 ). On binding of the pterin cofactor (H 4 biopterin) at the active site a conformational change, including a movement of this loop, has been observed for a double truncated form ("catalytic domain") of hPAH (35) . On this background, it was not unexpected to find that the steady-state kinetic parameters of the N376D mutant tetramer were comparable with those observed for multiple but partially deamidated wt-hPAH (24-h induction) (Table III) . Its V max was slightly higher than that of the multiple deamidated wt-hPAH and, in addition, a reduction by 33% in the [S] 0.5 (L-Phe) value and an increase (by 39%) in the K m (H 4 biopterin) was observed as compared with 46 and 29%, respectively, for the multiple deamidated (24-h induction) wt-hPAH (Table III) . The N376D mutant form also revealed an increase in the fold activation on preincubation with L-Phe when compared with the wt-hPAH (2-h induction) (Table III) , similar to that observed for the multiple deamidated hPAH (24-h induction). It has been proposed previously (34) that the autoregulatory sequence of the N-terminal regulatory domain partly blocks the access of substrate to the active site in the catalytic domain. On preincubation with L-Phe, there is a global conformational change in the enzyme (29) , including a possible repositioning of the N-terminal "arm" relative to the active site (34) , and an activation of the enzyme. A hinge region centered at Gly 33 has been proposed to be involved in this repositioning (34) , on the basis of a high crystallographic B-factor in this region of the rat enzyme, compatible with a high mobility. Although a movement at this   FIG. 4 . Reversed-phase chromatography of 32 P-labeled tryptic phosphopeptides of Asn 32 3 Asp and Gly 33 3 Ala mutant forms of hPAH. The fulllength mutant tetramers were phosphorylated at Ser 16 by PKA and digested with trypsin. The phosphopeptides were subjected to reversed-phase chromatography at time 0 (O) and after 32 h of incubation (---) in the phosphorylation medium at pH 7 and 37°C. 250-l fractions were collected every 15 s, followed by scintillation counting and analysis of the data by the PeakFit software program (SPSS Inc., Chicago). The elution pattern of the phosphopeptides revealed a main peak at t R ϳ31 min for the N32D and at t R ϳ36 min for the G33A mutant form. The heterogeneity of the eluted phosphopeptides may be related to alternative cleavage sites for tryptic proteolysis (1).
hinge region is probably involved in the regulation of the access of substrate to the active site, deamidation of Asn 32 does not seem to be involved in the increased L-Phe induced activation observed for the deamidated wt-hPAH (24 h), because the N32D mutant form revealed a similar degree of substrate activation as the wt-hPAH (2 h) (Table III) . By contrast, in the Gly 33 3 Ala/Val mutant forms the orientation of this arm seems to generate a more open entrance for the substrate to the active site, and thus explains their higher basal catalytic activity and reduced activation by L-Phe preincubation. In the catalytic domain, deamidation of Asn 376 significantly contributes to the increased substrate activation, as seen from the data (Table III) obtained for the N376D and the N32D/N376D mutant forms, when compared with the wt-hPAH (2 h). The second labile Asn residue in the catalytic domain, Asn 133 , is located in a long (18 residue) loop structure between the C␣1-and C␣2a-helix (Table IV; Fig. 5) , and a minor partial deamidation of Asn 133 was observed in enzyme preparations recovered after 24-h expression. However, the N133D mutant tetramer revealed steady-state kinetic properties comparable with that observed for the nondeamidated wt-hPAH (2 h) (Table III) . These results, together with the mass spectrometry data, indicate that deamidation of Asn 133 is unlikely to contribute to the kinetic TABLE IV An overview of the nearest neighbor amino acids, secondary structure, and three-dimensional structural interactions of the Asn residues in the catalytic domain of hPAH and their predicted deamidation rates t 1 ⁄2 represents the first-order deamidation half-times predicted from the primary amino acid sequence (10, 17) , and C D is the deamidation coefficient, an estimate of the relative rates of deamidation based on both the nearest neighbor amino acids and the three-dimensional structure of ⌬N117-hPAH (Protein Data Bank code 2PAH) (17 differences observed between the 2-and the 24-h expressed enzyme.
Considering all the data discussed above, the double mutant form N32D/N376D represents so far the best model enzyme which mimics the highly deamidated wt-hPAH (24 h). It is also a protein preparation with less microheterogeneity and may thus represent an interesting molecular form in the current efforts to crystallize and solve the structure of the full-length tetrameric enzyme. Thus, nonenzymatic deamidation of Asn residues introduces a time-dependent microheterogeneity that may be related to the reported time-dependent loss of diffraction power of the hPAH crystals (36) .
Structural and Functional Considerations of the Stable Asn Residues in the Catalytic Domain-Although the six stable Asn residues observed in the catalytic domain of hPAH are all located on the surface (Table IV) , their nearest neighbor amino acids and the structural constraints in the polypeptide backbone represents the protection against their deamidation (17) ( Table IV) (10, 17) , and they are in addition stabilized by hydrogen bonds and/or by their location in ␣-helical structures (Table IV) , which results in high deamidation coefficients (40 Ͻ C D Ͻ 2100) (Table IV) (17) . This computational prediction of stable Asn residues was confirmed by MALDI-TOF mass spectrometry of the corresponding tryptic peptides from the 24-h expressed wt-hPAH with single monoisotopic mass peaks, corresponding to fully amidated tryptic peptides as seen for the 2-h expressed enzyme (Table II) (Table IV; Fig. 5 ). Interestingly, in the N167D mutant tetramer the repulsive electrostatic interaction between the negatively charged carboxyl groups of Asp 167 and Asp 163 resulted in similar kinetic properties of the mutant form as the wt-hPAH (24-h induction) (Table III) . The importance of the conserved Asn residue at this position is further supported by the finding of an Asn 167 3 Ile mutation in a PKU patient (37) . Moreover, Asn 207 and Asn 223 also seem to have a structural role in hPAH. The substitution of Asn 207 and Asn 223 by Asp residues resulted in tetrameric proteins with kinetic properties very different from both the nondeamidated and deamidated wt-hPAH, including a reduced catalytic efficiency (Table III) . Asn 223 is located in a loop between the C␣4 and C␣5 helices but is stabilized by hydrogen bonding to two residues (Table IV; Fig. 5 ). The same is true for Asn 393 , located in a long loop structure between the C␣11 and C␣12 helices, and is stabilized by two hydrogen bonds to Ser 298 (Table IV ; Fig. 5 ). The N393D mutant tetramer revealed a low positive kinetic cooperativity of L-Phe binding and a low degree of substrate activation, as compared with the wt-hPAH (2 h), and thus support a stabilizing structural/functional role of this residue as well. With respect to Asn 401 , this residue is located in the middle of the C␣12-helix (38) and was therefore not considered to be a candidate for deamidation, although the N401D mutant enzyme revealed kinetic properties comparable with the highly deamidated wt-hPAH (Table  III) . Finally, it should be mentioned that Asn 426 is a highly conserved residue within mammalian PAHs, and although hydrogen-bonded to the Phe 410 main chain, it is part of a short flexible hinge region (Asp 425 -Gln 429 ) (36) just in front of C␣14-helix (38) , the beginning of the tetramerization motif (Table  IV) . This short hinge region (Asp 425 -Gln 429 ) has been assigned a function in the tetramerization of dimers and the cooperative binding of substrate to tetrameric wt-hPAH (23) . Interestingly, in contrast to the Thr 427 3 Pro substitution (23), the Asn 426 3 Asp mutation did not interfere with the tetramer 7 dimer equilibrium characteristic of wt-hPAH nor with the limited tryptic proteolysis (data not shown) or the cooperativity for L-Phe of the tetrameric enzyme (Table III) . By MALDI-TOF mass spectrometry of the tryptic peptides from wt-hPAH, it was also possible to recover the peptide containing Asn 438 (Table II) which did not show any evidence of deamidation in the 24-h expressed enzyme, as predicted from the estimated deamidation coefficient (C D ϭ 46) (17) . Asn 438 is located on the terminal ␣-helix that is part of the tetramerization domain, and interactions with the other amino acids in the helical structure are expected to protect it from undergoing a deamidation reaction (14) .
The Enzyme Phenotype of the Disease-associated Mutations Asn 167 3 Ile and Asn 207 3 Asp-More than 400 mutations associated with PKU/hyperphenylalanineemia have been identified so far in the PAH gene (39) (data.mch.mcgill.ca/pahdb_ new), but only three of them have been reported in the codons for Asn residues, i.e. N167I, N207D, and N207S. The N167I mutation has been found in a few PKU patients in Wales, Scotland, and Belgium (37), but so far no information has been reported on their metabolic and enzymatic phenotypes. Compared with wt-hPAH (2-h induction at 28°C), the N167I mutation revealed an almost 2-fold higher catalytic efficiency and a higher Hill coefficient for the L-Phe binding, although the apparent V max was reduced by about 50% (Table III) . In addition, the K m value for the pterin cofactor was decreased (Table  III) . Thus, the kinetic properties of the recombinant N167I tetramer do not explain why the mutation is associated with PKU. However, some PKU-related mutant forms are characterized by their reduced cellular stability (20, 26, 40) , and degradation of misfolded mutant proteins has been proposed as a general mechanism whereby a missense mutation leads to PKU/hyperphenylalanineemia (20, 26, 40) . The N167I mutant gave a low recovery of the tetrameric form on size-exclusion chromatography after cleavage of the fusion protein (data not shown) due to aggregation, and the steady-state kinetics were therefore determined using the tetrameric fusion protein. An isoleucine at this position may destabilize the secondary structure (Fig. 5) , and the presence of a hydrophobic residue on the outside of the ␣-helix, accessible to the solvent, may explain the tendency of the N167I mutant form to aggregate. Because codon 167 is located at the end of exon 5 in the hPAH gene, one should also consider the possibility that the mutation may affect the splicing of this exon. The N207D mutation has been identified in a Korean PKU patient as a compound heterozygote with the mutant allele Y325X (41), but no information has yet been reported on the metabolic and enzymatic phenotype of this heteroallelic genotype. The recombinant N207D mutant tetramer revealed a decreased V max value as well as a decreased affinity for L-Phe and an increased affinity for the pterin cofactor relative to wt-hPAH, but it did not show any kinetic cooperativity of L-Phe binding and no activation by L-Phe preincubation. Furthermore, the dramatic effect shown on tryptic proteolysis and temperature stability by the isolated tetrameric mutant enzyme indicates that the mutant protein is in a rather open conformational state and thus more susceptible to intracellular proteolysis than the wild-type hPAH. Thus, the expected enzymatic and metabolic phenotype of the N207D/ Y325X alleles is a classic PKU. The Asn 207 is located in the middle of the C␣4-helix of hPAH and is a highly conserved residue in PAH of different species, also suggesting an important structural role. It is stabilized by a hydrogen bond between Asn 207 N␦2 and Ala 202 carbonyl oxygen (3.13 Å) (located in the loop between C␣3-helix and C␣4-helix) and an electrostatic attraction to Tyr 198 carbonyl oxygen (3.6 Å) (located in the end of C␣3-helix) (Fig. 5) . The negative charge on the mutant Asp residue is likely to induce an electrostatic repulsion with both the carbonyl groups of Ala 202 and Tyr 198 (Fig. 5) and therefore disrupt the tertiary structure in this region by moving the ␣-helices away from each other.
Concluding Remarks-Post-translational modifications of proteins are important in the regulation of many cellular processes, providing a way to specifically change the structure and function of target proteins. Although phosphorylation and acetylation have received the most attention, nonenzymatic deamidation of labile Asn residues is also a frequently occurring post-translational modification in proteins (42) . The reaction mechanism of this hydrolytic reaction (6) and the main factors that determine the wide range of rate constants observed in individual proteins (and peptides) (42) are also well characterized. Recently, a computer algorithm was developed for the precise prediction of these rate constants, based on the contribution of the primary structure (notably the nearest neighbor amino acids in the n ϩ 1 position) and the threedimensional structure (16, 32) . Our recent (1) and present studies on the multiple Asn deamidations in hPAH represent another example of the high predictive value of this algorithm. Moreover, it is also well established that the deamidations of Asn residues in target proteins occur in vivo at rates that often exceed those observed in vitro (42) , as first shown for the multiple deamidations in the mitochondrial protein cytochrome c (31), due to the effects of the physiological temperature (37°C) and solution properties (7, 42) . Much less information is, however, available on the effects of deamidation on the structure and function of the target proteins. The deamidation of Asn residues results in two products, Asp and iso-Asp (9, 33), which have the same effect on the net charge of the protein.
Because iso-Asp also changes the peptide backbone (33) , it is, however, not straightforward to predict the overall structural effect (structural isomerization) of protein deamidation(s). On the other hand, their functional effects can be tested more easily. Thus, it has been reported that deamidation(s) of Asn residues in proteins can both markedly reduce (15) or increase (Refs. 1 and 4 and the present study) their biological activity and may also represent a "molecular timer" in the turnover of relatively long lived proteins (10) . The most dramatic biological effect of protein deamidation was recently described for the anti-apoptotic protein Bcl-X L (43) . Thus, on deamidation of Asn 52 and Asn 66 in a surface-exposed loop structure, the antiapoptotic activity is lost by changing its interaction with target proteins (BH3 domain-only proteins). Equally interesting was the finding that the deamidations were observed to be suppressed by the interaction of Bcl-X L with a specific retinoblastoma protein. Thus, specific protein-protein interactions may represent a third structural factor in determining the rate of deamidation of Asn residues in target proteins in vivo.
